Generation Lab is an Aging Diagnostics & Biomarkers company founded in 2021 and based in San Francisco, United States. It has raised $15M in total funding, most recently a Seed in 2025.

Generation Lab launches SystemAge 2.1 with separate biological age assessments for females and males.
SystemAge is Generation Lab's biological-age diagnostic, built on the discovery of a non-linear DNA-methylation curve of aging. From a standard blood sample it quantifies the pace of aging across 19 distinct physiological systems, including cardiovascular, immune, metabolic and reproductive function, instead of returning a single composite clock number. The company markets it as a preventive test that detects aging signals before symptoms appear, letting clinicians and individuals see which organ systems are aging faster and track how interventions change those trajectories over time. Generation Lab reports adoption across more than 275 clinics.